The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Palmoplantar Pustulosis Market Over The 2026–2030 Period?
The palmoplantar pustulosis market has experienced significant expansion in recent years. This market is projected to expand from $2.09 billion in 2025 to $2.26 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. Historically, this growth has been driven by factors such as the scarcity of effective treatments for chronic skin conditions, a heavy dependence on corticosteroids and topical agents, prolonged diagnostic periods for pustular psoriasis, inadequate patient knowledge regarding disease management, and a healthcare system primarily centered around hospitals.
The palmoplantar pustulosis market is poised for significant expansion in the upcoming years, with projections indicating a rise to $3.03 billion by 2030, showcasing a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period is fueled by the introduction of innovative biologics and systemic treatments, a greater acceptance of targeted immunomodulators, the advancement of teledermatology and digital health solutions, increased uptake of home-based phototherapy, and broader reach of online and retail pharmacies. Prominent trends for the forecast period involve a surge in the adoption of biologic therapies, expanded application of targeted immunomodulators, wider availability of home-based phototherapy alternatives, the integration of teledermatology for persistent skin conditions, and enhanced access to treatments via online pharmacies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22090&type=smp
Which Drivers Are Supporting The Palmoplantar Pustulosis Market Growth?
The anticipated rise in skin disorder cases is projected to drive expansion within the palmoplantar pustulosis market. Skin disorders are defined as ailments impacting the skin’s structure, its functions, or its visual characteristics. The growing occurrence of skin disorders is attributable to shifts in environmental factors, personal lifestyle choices, and inherent genetic susceptibilities. For example, environmental elements like atmospheric pollution, severe climatic patterns, and contact with detrimental chemicals can irritate the skin, potentially resulting in conditions such as eczema or acne. Palmoplantar pustulosis is a persistent skin condition primarily affecting the palms of the hands and soles of the feet, characterized by the formation of pustules, redness, and scaling. This condition can be addressed with diverse treatments aimed at enhancing skin health and reducing discomfort. Illustratively, data from December 2023, reported by the National Institutes of Health (NIH), the principal medical research agency of the U.S. government, indicated that the global prevalence of atopic dermatitis stood at 2.6%, impacting approximately 204 million individuals globally. Consequently, the rising prevalence of skin disorders is a key impetus for the expansion of the palmoplantar pustulosis market.
How Is Segmentation Applied In The Palmoplantar Pustulosis Market Segment Analysis?
The palmoplantar pustulosis market covered in this report is segmented –
1) By Treatment Type: Topical Treatments, Systemic Treatments, Biologics, Phototherapy
2) By Distribution Channel: Online Pharmacies, Retail Pharmacies
3) By Application: Hospitals, Dermatology Clinics, Homecare Settings
Subsegments:
1) By Topical Treatments: Corticosteroids, Vitamin D Analogues, Calcineurin Inhibitors, Keratolytics
2) By Systemic Treatments: Retinoids, Immunosuppressants, Phosphodiesterase-4 (PDE4) Inhibitors, Corticosteroids
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors, Interleukin-12/23 (IL-12/23) Inhibitors
4) By Phototherapy: Narrowband UVB Therapy (NB-UVB), Psoralen plus Ultraviolet A (PUVA) Therapy, Excimer Laser Therapy, Targeted Phototherapy
Which Trends Are Expected To Impact The Palmoplantar Pustulosis Market?
Leading companies active in the palmoplantar pustulosis market are concentrating on developing innovative treatments, such as monoclonal antibodies that target inflammatory pathways, to enhance patient outcomes. A monoclonal antibody (mAb) is an identical antibody created by a single B cell clone, designed to target a specific antigen for therapeutic or diagnostic purposes. For example, in August 2023, Kyowa Kirin Co., Ltd., a pharmaceutical company situated in Japan, secured a partial change approval for LUMICEF for palmoplantar pustulosis in Japan. LUMICEF is a targeted therapy that obstructs IL-17, providing quick and prolonged relief for inflammatory conditions like psoriasis and palmoplantar pustulosis. Its aim is to decrease inflammation and improve the quality of life for patients dealing with these chronic conditions.
Who Are The Companies Participating In The Palmoplantar Pustulosis Market Environment?
Major companies operating in the palmoplantar pustulosis market are Pfizer Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis International AG, GlaxoSmithKline PLC (GSK), Amgen Inc., Chugai Pharmaceutical Co. Ltd., Janssen Pharmaceuticals Inc., Kyowa Kirin Co. Ltd., Almirall S.A., MorphoSys AG, MoonLake Immunotherapeutics AG, Aristea Therapeutics Inc., AnaptysBio Inc., Kamari Pharma Ltd., Johnson & Johnson, AstraZeneca, Eli Lilly and Company, Bayer AG, Merck & Co. Inc., UCB S.A., Boehringer Ingelheim International GmbH, Arcutis Biotherapeutics, Affibody AB, LEO Pharma A/S, Galderma, Incyte Corporation, Takeda Pharmaceutical Company Ltd., Roivant Sciences
Get The Full Palmoplantar Pustulosis Market Report:
https://www.thebusinessresearchcompany.com/report/palmoplantar-pustulosis-global-market-report
Which Region Dominates The Palmoplantar Pustulosis Market By Market Share?
North America was the largest region in the palmoplantar pustulosis market in 2025. The regions covered in the palmoplantar pustulosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Palmoplantar Pustulosis Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/palmoplantar-pustulosis-global-market-report
Browse Through More Reports Similar to the Global Palmoplantar Pustulosis Market 2026, By The Business Research Company
Hypertrophic And Keloid Scar Treatment Market Report 2026
Scar Treatment Market Report
https://www.thebusinessresearchcompany.com/report/scar-treatment-global-market-report
Rare Diseases Treatment Market Report
https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model